Medscape48m
Dupilumab Beneficial When Antihistamines Fall Short for Chronic Spontaneous Urticaria
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
ENDPOINTS NEWS2h
In­cyte’s bet on Escient hits a snag as safe­ty is­sues ham­per Phase 2 chron­ic hives tri­al
Incyte’s $750 million buyout of Escient Pharmaceuticals is in a rough patch as a mid-stage chronic hives candidate was ...
Rolling Out2h
6 causes of itchy breast and nipples
Itchy breasts and nipples can be an uncomfortable experience that disrupts daily life. While occasional itching may seem ...
Medscape3h
FDA Considers New Dupilumab Data for Chronic Spontaneous Urticaria Indication
The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
My mum recently died after a UTI and now my wife’s got one – could she have caught it from the loo seat?
AS the cold weather takes hold, it creates the perfect breeding ground for viruses like flu, RSV and norovirus. While in most ...